Plasmapheresis is a blood-filtering procedure used to treat autoimmune and blood disorders where harmful substances in the plasma are causing damage to the body. It works by removing your plasma (the liquid part of blood), discarding it, and returning your blood cells mixed with a replacement fluid. The conditions it treats range from rare neurological diseases to life-threatening blood clotting disorders.
How the Procedure Works
During plasmapheresis, a machine draws your blood, spins it to separate the plasma from the red blood cells, white blood cells, and platelets, then discards the plasma entirely. Your blood cells are mixed with a replacement fluid, often containing a protein called albumin, and returned to your body through an intravenous or central line catheter.
The logic is straightforward: if your plasma contains antibodies or other molecules that are attacking your own tissues, removing and replacing that plasma removes those harmful molecules. This doesn’t cure the underlying condition, but it can rapidly reduce the concentration of damaging substances while other treatments take effect. Think of it as hitting a reset button on the liquid portion of your blood.
Neurological Conditions
Some of the most common uses for plasmapheresis involve the nervous system. Two conditions in particular drive a large share of procedures: myasthenia gravis and Guillain-Barré syndrome.
Myasthenia Gravis
Myasthenia gravis is a condition where antibodies attack the connection between nerves and muscles, causing weakness that can become severe enough to impair breathing. Plasmapheresis removes those antibodies from circulation. A meta-analysis published in Frontiers in Neurology found that at least 50% of patients responded to plasma exchange across all studies reviewed, with statistically significant improvements on established disease severity scales. When compared head-to-head with another common treatment (intravenous immunoglobulin, or IVIG), plasma exchange showed a 19% higher response rate in acute flares, a statistically significant advantage.
Plasma exchange also tends to work faster. Studies have observed shorter time on a ventilator for patients treated with plasma exchange compared to IVIG, which matters enormously during a myasthenic crisis when breathing muscles are failing. For patients scheduled for surgical removal of the thymus gland, a common treatment for myasthenia gravis, receiving plasma exchange beforehand speeds post-operative recovery, improves long-term outcomes, and reduces the chance of a crisis during follow-up.
Guillain-Barré Syndrome
Guillain-Barré syndrome is a condition where the immune system attacks the protective coating around nerves, causing rapid-onset weakness that can progress to paralysis. Plasmapheresis is one of only two proven treatments (alongside IVIG) and is most effective when started within the first two weeks of symptoms. By stripping out the antibodies driving the nerve damage, it can shorten the duration and severity of the illness.
Other Neurological Uses
Plasmapheresis is also used in chronic inflammatory demyelinating polyneuropathy (a longer-lasting cousin of Guillain-Barré), multiple sclerosis relapses that don’t respond to steroids, and neuromyelitis optica, a condition sometimes mistaken for MS that involves inflammation of the optic nerve and spinal cord.
Blood Disorders
Thrombotic Thrombocytopenic Purpura
Thrombotic thrombocytopenic purpura (TTP) is arguably the condition where plasmapheresis has made the most dramatic difference. TTP causes tiny blood clots to form throughout the body, consuming platelets and damaging organs. Before plasma exchange became standard treatment, the mortality rate exceeded 90%. With plasma exchange, survival rates jumped to between 75% and 92%.
Treatment starts as soon as TTP is suspected, without waiting for confirmatory testing. One full plasma volume (roughly 40 milliliters per kilogram of body weight) is exchanged daily until platelet counts recover and remain stable. If the initial response is poor, sessions may be increased to twice daily. Flare-ups and late recurrences require restarting daily exchanges.
Autoimmune and Kidney Conditions
Beyond the nervous system and blood, plasmapheresis treats several conditions where antibodies cause organ damage. Goodpasture syndrome, in which antibodies attack the kidneys and lungs, is a classic example. Removing those specific antibodies through plasma exchange can prevent irreversible kidney failure if caught early enough.
It is also used in certain forms of kidney transplant rejection, where antibodies target the transplanted organ, and in some cases of lupus with severe organ involvement. For patients with extremely high levels of antibodies that make them incompatible with available kidney donors, repeated plasma exchange sessions can lower antibody levels enough to make transplantation possible.
What To Expect During Treatment
Each plasmapheresis session lasts a few hours. A standard treatment course involves sessions every two to three days, typically totaling 5 to 10 sessions depending on the condition being treated and how you respond. Some chronic conditions require ongoing maintenance sessions at longer intervals.
You’ll need reliable venous access for the procedure. Some patients can use peripheral veins in the arm, similar to a standard blood draw. A study of chronic plasmapheresis patients found that about 64% successfully completed their courses using peripheral access alone, while roughly a third needed a central venous catheter, usually because their arm veins couldn’t sustain the required blood flow. Central lines are placed in larger veins, typically in the neck or chest, and may be necessary for patients needing frequent or long-term treatment.
During the session, you lie still while the machine cycles your blood. Some people feel lightheaded, chilled, or experience tingling around the lips and fingers, which happens when calcium levels temporarily dip during the exchange. These side effects are generally mild and resolve quickly. More significant complications like infection at the catheter site or drops in blood pressure are less common but can occur, particularly in patients requiring central lines over many sessions.
Limitations of Plasma Exchange
Plasmapheresis is a powerful tool, but it works as a bridge rather than a standalone cure. Because your body continues producing the harmful antibodies or molecules, the effect of each exchange is temporary. Most patients need concurrent treatment with medications that suppress the immune system to prevent the problem from rebuilding. The procedure also removes beneficial proteins along with harmful ones, including clotting factors and protective antibodies, which is why sessions are carefully spaced and replacement fluids are chosen to minimize these losses.
For some conditions, IVIG achieves similar results with fewer logistical demands, since it can be given through a simple IV without specialized equipment. The choice between the two often comes down to availability, the speed of response needed, and individual patient factors. In myasthenia gravis, for example, plasma exchange works somewhat faster, but IVIG is associated with shorter hospital stays overall. Mortality rates between the two treatments show no significant difference across most conditions where both are used.